218 related articles for article (PubMed ID: 33022452)
1. Mesenchyme-specific loss of Dot1L histone methyltransferase leads to skeletal dysplasia phenotype in mice.
Sutter PA; Karki S; Crawley I; Singh V; Bernt KM; Rowe DW; Crocker SJ; Bayarsaihan D; Guzzo RM
Bone; 2021 Jan; 142():115677. PubMed ID: 33022452
[TBL] [Abstract][Full Text] [Related]
2. Targeted disruption of the histone lysine 79 methyltransferase Dot1L in nephron progenitors causes congenital renal dysplasia.
Wang F; Ngo J; Li Y; Liu H; Chen CH; Saifudeen Z; Sequeira-Lopez MLS; El-Dahr SS
Epigenetics; 2021 Nov; 16(11):1235-1250. PubMed ID: 33315499
[TBL] [Abstract][Full Text] [Related]
3. The Role of
Jo SY; Domowicz MS; Henry JG; Schwartz NB
JBMR Plus; 2020 Feb; 4(2):e10254. PubMed ID: 32083237
[TBL] [Abstract][Full Text] [Related]
4. Increased susceptibility to develop spontaneous and post-traumatic osteoarthritis in Dot1l-deficient mice.
Cornelis FMF; de Roover A; Storms L; Hens A; Lories RJ; Monteagudo S
Osteoarthritis Cartilage; 2019 Mar; 27(3):513-525. PubMed ID: 30513362
[TBL] [Abstract][Full Text] [Related]
5. Single-cell transcriptomics defines Dot1L interacting partners and downstream target genes in the mouse molar dental pulp.
Guzzo R; Enkhmandakh B; Becker T; Joshi P; Robson P; Vijaykumar A; Mina M; Shin DG; Bayarsaihan D
Int J Dev Biol; 2022; 66(7-8-9):391-400. PubMed ID: 36942693
[TBL] [Abstract][Full Text] [Related]
6. Differential Methylation of H3K79 Reveals DOT1L Target Genes and Function in the Cerebellum In Vivo.
Bovio PP; Franz H; Heidrich S; Rauleac T; Kilpert F; Manke T; Vogel T
Mol Neurobiol; 2019 Jun; 56(6):4273-4287. PubMed ID: 30302725
[TBL] [Abstract][Full Text] [Related]
7. ESET histone methyltransferase is essential to hypertrophic differentiation of growth plate chondrocytes and formation of epiphyseal plates.
Yang L; Lawson KA; Teteak CJ; Zou J; Hacquebord J; Patterson D; Ghatan AC; Mei Q; Zielinska-Kwiatkowska A; Bain SD; Fernandes RJ; Chansky HA
Dev Biol; 2013 Aug; 380(1):99-110. PubMed ID: 23652029
[TBL] [Abstract][Full Text] [Related]
8. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the DNA damage response and gene expression by the Dot1L histone methyltransferase and the 53Bp1 tumour suppressor.
FitzGerald J; Moureau S; Drogaris P; O'Connell E; Abshiru N; Verreault A; Thibault P; Grenon M; Lowndes NF
PLoS One; 2011 Feb; 6(2):e14714. PubMed ID: 21383990
[TBL] [Abstract][Full Text] [Related]
10. Differentiation and localization of interneurons in the developing spinal cord depends on DOT1L expression.
Gray de Cristoforis A; Ferrari F; Clotman F; Vogel T
Mol Brain; 2020 May; 13(1):85. PubMed ID: 32471461
[TBL] [Abstract][Full Text] [Related]
11. The disruptor of telomeric silencing 1-like (DOT1L) promotes peritoneal fibrosis through the upregulation and activation of protein tyrosine kinases.
Tao M; Shi Y; Chen H; Li J; Wang Y; Ma X; Du L; Wang Y; Yang X; Hu Y; Zhou X; Zhong Q; Yan D; Qiu A; Zhuang S; Liu N
Mol Biomed; 2024 Jan; 5(1):3. PubMed ID: 38172378
[TBL] [Abstract][Full Text] [Related]
12. Conditional Deletion of Indian Hedgehog in Limb Mesenchyme Results in Complete Loss of Growth Plate Formation but Allows Mature Osteoblast Differentiation.
Amano K; Densmore MJ; Lanske B
J Bone Miner Res; 2015 Dec; 30(12):2262-72. PubMed ID: 26094741
[TBL] [Abstract][Full Text] [Related]
13. Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapy.
Mao Y; Sun Y; Wu Z; Zheng J; Zhang J; Zeng J; Lee C; Kim JK
Cell Death Dis; 2021 Dec; 12(12):1141. PubMed ID: 34887387
[TBL] [Abstract][Full Text] [Related]
14. The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure.
Jones B; Su H; Bhat A; Lei H; Bajko J; Hevi S; Baltus GA; Kadam S; Zhai H; Valdez R; Gonzalo S; Zhang Y; Li E; Chen T
PLoS Genet; 2008 Sep; 4(9):e1000190. PubMed ID: 18787701
[TBL] [Abstract][Full Text] [Related]
15. Maternal DOT1L is dispensable for mouse development.
Liao J; Szabó PE
Sci Rep; 2020 Nov; 10(1):20636. PubMed ID: 33244015
[TBL] [Abstract][Full Text] [Related]
16. The Histone Methyltransferase DOT1L Is Essential for Humoral Immune Responses.
Kealy L; Di Pietro A; Hailes L; Scheer S; Dalit L; Groom JR; Zaph C; Good-Jacobson KL
Cell Rep; 2020 Dec; 33(11):108504. PubMed ID: 33326791
[TBL] [Abstract][Full Text] [Related]
17. Histone methyltransferase Dot1L plays a role in postembryonic development in Xenopus tropicalis.
Wen L; Fu L; Guo X; Chen Y; Shi YB
FASEB J; 2015 Feb; 29(2):385-93. PubMed ID: 25366346
[TBL] [Abstract][Full Text] [Related]
18. Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation.
Jo SY; Granowicz EM; Maillard I; Thomas D; Hess JL
Blood; 2011 May; 117(18):4759-68. PubMed ID: 21398221
[TBL] [Abstract][Full Text] [Related]
19. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.
Chen CW; Koche RP; Sinha AU; Deshpande AJ; Zhu N; Eng R; Doench JG; Xu H; Chu SH; Qi J; Wang X; Delaney C; Bernt KM; Root DE; Hahn WC; Bradner JE; Armstrong SA
Nat Med; 2015 Apr; 21(4):335-43. PubMed ID: 25822366
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer.
Zhang X; Liu D; Li M; Cao C; Wan D; Xi B; Li W; Tan J; Wang J; Wu Z; Ma D; Gao Q
J Hematol Oncol; 2017 Jan; 10(1):29. PubMed ID: 28114995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
